Rivaroxaban NOBEL 15 mg, Filmtabletten - 28 Swissmedic Key 68009005 Registration Holder NOBEL Pharma Schweiz AG Name Rivaroxaban NOBEL 15 mg, Filmtabletten Date of registration 28.04.2022 Original/Generic Generic Introduction of Sequence 28.04.2022 ATC-Classification Rivaroxaban (B01AF01) Revision date WHO WHO-DDD Valid until 27.04.2027 Index Therapeuticus (BSV) 60000. Show package size 28 Index Therapeuticus (Swissmedic) 06.03. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 14.08 Limitation Yes Limitation text
Deductible 10 % Consumer price 32.00 Feedback FB Daily cost GTIN 7680680090053 Medication Code Synthetika Pharmacode Disponibility
Composition rivaroxabanum 15 mg, mannitolum, carmellosum natricum conexum, hypromellosum, natrii laurilsulfas, cellulosum microcristallinum, magnesii stearas, Überzug: hypromellosum, macrogolum 3350, E 171, E 172 (rubrum), pro compresso obducto corresp. natrium max. 0.3292 mg. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Rivaroxabanum 15 mg
BAG: Active Agent Dose Rivaroxabanum 15 mg
Inactive agents Dose additional_information (Rubrum) Carmellosum Natricum Conexum Cellulosum Microcristallinum E 171 color. E 172 color. Hypromellosum Überzug Macrogol 3350 Magnesii Stearas Mannitol Natrii Laurilsulfas Pro Compresso Obducto
Source Data was imported : 08.07.2026
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
